Cleared Traditional

K102746 - MIRAGE FX

K102746 is the FDA 510(k) clearance for MIRAGE FX by Resmed, Ltd.. It is a Class 2 Anesthesiology device (product code BZD) cleared through the Traditional 510(k) pathway after a 96-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2010
Decision
96d
Days
Class 2
Risk

K102746 is an FDA 510(k) clearance for the MIRAGE FX. Classified as Ventilator, Non-continuous (respirator) (product code BZD), Class II - Special Controls.

Submitted by Resmed, Ltd. (San Diego, US). The FDA issued a Cleared decision on December 28, 2010 after a review of 96 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5905 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Resmed, Ltd. devices

Submission Details

510(k) Number K102746 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 23, 2010
Decision Date December 28, 2010
Days to Decision 96 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
44d faster than avg
Panel avg: 140d · This submission: 96d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code BZD Ventilator, Non-continuous (respirator)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5905
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BZD Ventilator, Non-continuous (respirator)

All 246
Devices cleared under the same product code (BZD) and FDA review panel - the closest regulatory comparables to K102746.
MIRAGE MICRO
K110444 · Resmed, Ltd. · Mar 2011
GOLIFE NASAL MASK
K110008 · Respironics, Inc. · Feb 2011
S9 VPAP ST WITH H5I
K102513 · Resmed, Ltd. · Jan 2011
GOLIFE NASAL MASK
K102502 · Respironics, Inc. · Dec 2010
PIXI PEDIATRIC MASK
K102224 · Resmed, Ltd. · Dec 2010
FISHER & PAYKEL HEALTHCARE BUBBLE CPAP SYSTEM
K100011 · Fisher &Paykel Healthcare , Ltd. · Oct 2010